Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2026 Filed Jan 21, 2026 18:29 UTC |
Schacterle AmyChief Regulatory Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 126,900 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001628280-26-002957 · wk-form4_1769038189.xml · derivative · entry 2 Schacterle Amy · CIK 0002042021 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,900 Underlying: Common Stock · 126,900 shares Expires 2036-01-16 F2 · derivative.exercise_date: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:29 UTC |
Schacterle AmyChief Regulatory Officer
|
GrantCommon Stock | 84,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002957 · wk-form4_1769038189.xml · nonDerivative · entry 1 Schacterle Amy · CIK 0002042021 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,303 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:29 UTC |
Doherty James J.President and CDO
|
GrantEmployee Stock Option (right to buy) · Derivative | 250,300 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001628280-26-002956 · wk-form4_1769038162.xml · derivative · entry 2 Doherty James J. · CIK 0002009718 · President and CDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,300 Underlying: Common Stock · 250,300 shares Expires 2036-01-16 F2 · derivative.exercise_date: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:29 UTC |
Doherty James J.President and CDO
|
GrantCommon Stock | 166,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002956 · wk-form4_1769038162.xml · nonDerivative · entry 1 Doherty James J. · CIK 0002009718 · President and CDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,900 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:31 UTC |
Siemers EricChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 148,700 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001628280-26-002959 · wk-form4_1769038268.xml · derivative · entry 2 Siemers Eric · CIK 0001866239 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,700 Underlying: Common Stock · 148,700 shares Expires 2036-01-16 F2 · derivative.exercise_date: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:31 UTC |
Siemers EricChief Medical Officer
|
GrantCommon Stock | 99,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002959 · wk-form4_1769038268.xml · nonDerivative · entry 1 Siemers Eric · CIK 0001866239 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,597 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:31 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 148,700 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001628280-26-002960 · wk-form4_1769038296.xml · derivative · entry 2 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,700 Underlying: Common Stock · 148,700 shares Expires 2036-01-16 F2 · derivative.exercise_date: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 18:31 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
GrantCommon Stock | 99,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002960 · wk-form4_1769038296.xml · nonDerivative · entry 1 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,933 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:32 UTC |
Zuga MattCFO & Chief Business Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 148,700 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001628280-26-002961 · wk-form4_1769038322.xml · derivative · entry 2 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,700 Underlying: Common Stock · 148,700 shares Expires 2036-01-16 F2 · derivative.exercise_date: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:32 UTC |
Zuga MattCFO & Chief Business Officer
|
GrantCommon Stock | 99,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002961 · wk-form4_1769038322.xml · nonDerivative · entry 1 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,084 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:30 UTC |
Barton RussellChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 126,900 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001628280-26-002958 · wk-form4_1769038220.xml · derivative · entry 2 Barton Russell · CIK 0001867418 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,900 Underlying: Common Stock · 126,900 shares Expires 2036-01-16 F2 · derivative.exercise_date: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:30 UTC |
Barton RussellChief Operating Officer
|
GrantCommon Stock | 84,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002958 · wk-form4_1769038220.xml · nonDerivative · entry 1 Barton Russell · CIK 0001867418 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,869 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 12, 2026 Filed Jan 12, 2026 18:50 UTC |
OConnell Daniel JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 5,388 | $1.73 | $9,306.69 |
DisclosureSEC source: 0001628280-26-001895 · wk-form4_1768261820.xml · nonDerivative · entry 3 OConnell Daniel Joseph · CIK 0001865136 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 593,510 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.6700 to $1.8400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2026 Filed Jan 12, 2026 18:51 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 8,548 | $1.71 | $14,658.11 |
DisclosureSEC source: 0001628280-26-001896 · wk-form4_1768261867.xml · nonDerivative · entry 4 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,800 F3 · shares: Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F5 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.6700 to $1.8400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 18:50 UTC |
OConnell Daniel JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 12,941 | $1.76 | $22,831.81 |
DisclosureSEC source: 0001628280-26-001895 · wk-form4_1768261820.xml · nonDerivative · entry 2 OConnell Daniel Joseph · CIK 0001865136 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598,898 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7100 to $1.8100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 18:51 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 5,200 | $1.76 | $9,169.16 |
DisclosureSEC source: 0001628280-26-001896 · wk-form4_1768261867.xml · nonDerivative · entry 3 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,348 F3 · shares: Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7100 to $1.8150. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 16:39 UTC |
Doherty James J.President and CDO
|
SaleCommon Stock | 6,467 | $1.82 | $11,768.65 |
DisclosureSEC source: 0001628280-26-001636 · wk-form4_1767994762.xml · nonDerivative · entry 2 Doherty James J. · CIK 0002009718 · President and CDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,033 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 18:50 UTC |
OConnell Daniel JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 8,143 | $1.82 | $14,815.37 |
DisclosureSEC source: 0001628280-26-001895 · wk-form4_1768261820.xml · nonDerivative · entry 1 OConnell Daniel Joseph · CIK 0001865136 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 611,839 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 18:51 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 30,092 | $1.82 | $54,866.74 |
DisclosureSEC source: 0001628280-26-001896 · wk-form4_1768261867.xml · nonDerivative · entry 2 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,548 F3 · shares: Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 18:51 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 6,819 | $1.82 | $12,379.21 |
DisclosureSEC source: 0001628280-26-001896 · wk-form4_1768261867.xml · nonDerivative · entry 1 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,640 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 23:52 UTC |
Zuga MattCFO & Chief Business Officer
|
SaleCommon Stock | 6,888 | $1.82 | $12,512.74 |
DisclosureSEC source: 0001628280-26-001898 · wk-form4_1768261959.xml · nonDerivative · entry 1 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,951 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 23:52 UTC |
Barton RussellChief Operating Officer
|
SaleCommon Stock | 3,530 | $1.86 | $6,561.56 |
DisclosureSEC source: 0001628280-26-001897 · wk-form4_1768261937.xml · nonDerivative · entry 1 Barton Russell · CIK 0001867418 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,269 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 25, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.8000 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 7, 2026 21:31 UTC |
OConnell Daniel JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 37,755 | $1.99 | $74,981.43 |
DisclosureSEC source: 0001628280-26-001263 · wk-form4_1767839464.xml · nonDerivative · entry 3 OConnell Daniel Joseph · CIK 0001865136 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 619,982 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0300. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 7, 2026 21:30 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 10,070 | $1.99 | $20,035.27 |
DisclosureSEC source: 0001628280-26-001262 · wk-form4_1767839440.xml · nonDerivative · entry 5 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,459 F4 · shares: Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F7 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0250. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 7, 2026 21:30 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 1,700 | $1.99 | $3,378.92 |
DisclosureSEC source: 0001628280-26-001262 · wk-form4_1767839440.xml · nonDerivative · entry 4 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,529 F5 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F6 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0200. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 02:31 UTC |
Zuga MattCFO & Chief Business Officer
|
SaleCommon Stock | 1,700 | $1.99 | $3,376.54 |
DisclosureSEC source: 0001628280-26-001265 · wk-form4_1767839507.xml · nonDerivative · entry 4 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,839 F5 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025. F6 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 02:31 UTC |
Zuga MattCFO & Chief Business Officer
|
SaleCommon Stock | 4,105 | $2.00 | $8,189.48 |
DisclosureSEC source: 0001628280-26-001265 · wk-form4_1767839507.xml · nonDerivative · entry 3 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,539 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 02:30 UTC |
Barton RussellChief Operating Officer
|
SaleCommon Stock | 1,700 | $1.99 | $3,378.07 |
DisclosureSEC source: 0001628280-26-001261 · wk-form4_1767839412.xml · nonDerivative · entry 3 Barton Russell · CIK 0001867418 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,799 F4 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 25, 2025. F5 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9550 to $2.0200. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 16:38 UTC |
Schacterle AmyChief Regulatory Officer
|
SaleCommon Stock | 1,097 | $1.98 | $2,176.23 |
DisclosureSEC source: 0001628280-26-001633 · wk-form4_1767994720.xml · nonDerivative · entry 1 Schacterle Amy · CIK 0002042021 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,703 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9550 to $2.0100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 16:39 UTC |
Doherty James J.President and CDO
|
SaleCommon Stock | 1,700 | $1.99 | $3,379.43 |
DisclosureSEC source: 0001628280-26-001636 · wk-form4_1767994762.xml · nonDerivative · entry 1 Doherty James J. · CIK 0002009718 · President and CDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,500 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9550 to $2.0200. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Number of securities reported as beneficially owned by Mr. Doherty following the reported transaction reflects the correction of a typographical error in the Form 4 report filed January 7, 2025, which overreported the number of RSUs granted to Mr. Doherty on January 6, 2025, by 400 shares. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:31 UTC |
Siemers EricChief Medical Officer
|
SaleCommon Stock | 6,834 | $1.97 | $13,442.48 |
DisclosureSEC source: 0001628280-26-001264 · wk-form4_1767839485.xml · nonDerivative · entry 2 Siemers Eric · CIK 0001866239 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,464 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:31 UTC |
OConnell Daniel JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 5,102 | $1.97 | $10,031.55 |
DisclosureSEC source: 0001628280-26-001263 · wk-form4_1767839464.xml · nonDerivative · entry 2 OConnell Daniel Joseph · CIK 0001865136 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 657,737 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $2.0000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:30 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 3,801 | $1.97 | $7,476.57 |
DisclosureSEC source: 0001628280-26-001262 · wk-form4_1767839440.xml · nonDerivative · entry 3 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,229 F4 · shares: Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $2.0000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:30 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 7,097 | $1.97 | $13,961.22 |
DisclosureSEC source: 0001628280-26-001262 · wk-form4_1767839440.xml · nonDerivative · entry 2 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,030 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2024. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $2.0000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 02:31 UTC |
Zuga MattCFO & Chief Business Officer
|
SaleCommon Stock | 5,100 | $1.97 | $10,027.62 |
DisclosureSEC source: 0001628280-26-001265 · wk-form4_1767839507.xml · nonDerivative · entry 2 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,644 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 02:30 UTC |
Barton RussellChief Operating Officer
|
SaleCommon Stock | 3,618 | $1.97 | $7,114.44 |
DisclosureSEC source: 0001628280-26-001261 · wk-form4_1767839412.xml · nonDerivative · entry 2 Barton Russell · CIK 0001867418 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,499 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:31 UTC |
Siemers EricChief Medical Officer
|
SaleCommon Stock | 4,000 | $1.96 | $7,834.80 |
DisclosureSEC source: 0001628280-26-001264 · wk-form4_1767839485.xml · nonDerivative · entry 1 Siemers Eric · CIK 0001866239 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,298 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:31 UTC |
OConnell Daniel JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 4,649 | $1.97 | $9,163.18 |
DisclosureSEC source: 0001628280-26-001263 · wk-form4_1767839464.xml · nonDerivative · entry 1 OConnell Daniel Joseph · CIK 0001865136 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662,839 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9000 to $2.0600. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:30 UTC |
Meisner Derek MChief Legal Officer & Corp Sec
|
SaleCommon Stock | 4,000 | $1.96 | $7,838.00 |
DisclosureSEC source: 0001628280-26-001262 · wk-form4_1767839440.xml · nonDerivative · entry 1 Meisner Derek M · CIK 0001752461 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,127 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2024. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9200 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:31 UTC |
Zuga MattCFO & Chief Business Officer
|
SaleCommon Stock | 4,000 | $1.96 | $7,842.40 |
DisclosureSEC source: 0001628280-26-001265 · wk-form4_1767839507.xml · nonDerivative · entry 1 Zuga Matt · CIK 0001790214 · CFO & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,744 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:30 UTC |
Barton RussellChief Operating Officer
|
SaleCommon Stock | 4,000 | $1.96 | $7,832.40 |
DisclosureSEC source: 0001628280-26-001261 · wk-form4_1767839412.xml · nonDerivative · entry 1 Barton Russell · CIK 0001867418 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,117 F1 · shares: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9800. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:49 UTC |
Golumbeski GeorgeDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001586660-25-000003 · wk-form4_1762811342.xml · derivative · entry 1 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-11-06 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a three-year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date and shall vest and become immediately exercisable prior to the effectiveness of a change in control. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:57 UTC |
Fountain Nathan BDirector
|
GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001576885-25-000080 · wk-form4_1749156801.xml · derivative · entry 2 Fountain Nathan B · CIK 0001869596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-06-04 F2 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:57 UTC |
Fountain Nathan BDirector
|
GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001576885-25-000080 · wk-form4_1749156801.xml · nonDerivative · entry 1 Fountain Nathan B · CIK 0001869596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,050 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 22:05 UTC |
Stoppel LauraDirector
|
GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001576885-25-000084 · wk-form4_1749160924.xml · derivative · entry 2 Stoppel Laura · CIK 0001865119 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-06-04 F3 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option and RSUs for the benefit of the R.A. Capital Healthcare Fund, L.P. (the "Fund"), R.A. Capital Nexus Fund II, L.P. (the "Nexus Fund II") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement, as applicable, which will offset advisory fees owed by the Fund, Nexus Fund II and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and RSUs and underlying common stock. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 22:05 UTC |
Stoppel LauraDirector
|
GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001576885-25-000084 · wk-form4_1749160924.xml · nonDerivative · entry 1 Stoppel Laura · CIK 0001865119 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,800 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option and RSUs for the benefit of the R.A. Capital Healthcare Fund, L.P. (the "Fund"), R.A. Capital Nexus Fund II, L.P. (the "Nexus Fund II") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement, as applicable, which will offset advisory fees owed by the Fund, Nexus Fund II and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and RSUs and underlying common stock. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:51 UTC |
Porter DerrellDirector
|
GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001576885-25-000078 · wk-form4_1749156630.xml · derivative · entry 2 Porter Derrell · CIK 0001706400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-06-04 F2 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:51 UTC |
Porter DerrellDirector
|
GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001576885-25-000078 · wk-form4_1749156630.xml · nonDerivative · entry 1 Porter Derrell · CIK 0001706400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,800 F1 · shares: Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 22:12 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund II, L.P.Director
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001415889-25-015836 · form4-06052025_100655.xml · derivative · entry 5 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund II, L.P. · CIK 0001825376 · Director Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-06-04 F7 · derivative.exercise_date: Represents the grant of an option to Dr. Stoppel pursuant to the Issuer's non-employee director compensation policy. The shares subject to the option will vest on the earlier of June 4, 2026 or the 2026 annual stockholder meeting, subject to Dr. Stoppel's continuous service as a director through such vesting date. F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II") and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. F3 · ownership.nature: Under Dr. Stoppel's arrangement with the Adviser, Dr. Stoppel holds the RSU and the option for the benefit of the Fund and the Nexus Fund II. Dr. Stoppel is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement of the RSU, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the RSU, the option and underlying common stock. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 22:12 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund II, L.P.Director
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015836 · form4-06052025_100655.xml · nonDerivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund II, L.P. · CIK 0001825376 · Director Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 12,800 F1 · shares: Represents the grant of a restricted stock unit ("RSU") award to Laura Stoppel pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of June 4, 2026 or the Issuer's 2026 annual stockholder meeting, subject to Dr. Stoppel's continuous service as a director through such vesting date. F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II") and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. F3 · ownership.nature: Under Dr. Stoppel's arrangement with the Adviser, Dr. Stoppel holds the RSU and the option for the benefit of the Fund and the Nexus Fund II. Dr. Stoppel is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement of the RSU, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the RSU, the option and underlying common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.